LLY

1,017.19

-2.72%↓

JNJ

244.07

+0.3%↑

ABBV

227.12

-2.44%↓

NVS

165.06

-0.79%↓

MRK

120.66

-0.62%↓

LLY

1,017.19

-2.72%↓

JNJ

244.07

+0.3%↑

ABBV

227.12

-2.44%↓

NVS

165.06

-0.79%↓

MRK

120.66

-0.62%↓

LLY

1,017.19

-2.72%↓

JNJ

244.07

+0.3%↑

ABBV

227.12

-2.44%↓

NVS

165.06

-0.79%↓

MRK

120.66

-0.62%↓

LLY

1,017.19

-2.72%↓

JNJ

244.07

+0.3%↑

ABBV

227.12

-2.44%↓

NVS

165.06

-0.79%↓

MRK

120.66

-0.62%↓

LLY

1,017.19

-2.72%↓

JNJ

244.07

+0.3%↑

ABBV

227.12

-2.44%↓

NVS

165.06

-0.79%↓

MRK

120.66

-0.62%↓

Search

ResMed Inc

Abrir

SetorSaúde

258.44 0.7

Visão Geral

Variação de preço das ações

24h

Atual

Mín

254.75

Máximo

262.01

Indicadores-chave

By Trading Economics

Rendimento

44M

393M

Vendas

87M

1.4B

P/E

Médio do Setor

27.323

121.746

Rendimento de Dividendos

0.83

Margem de lucro

27.593

Funcionários

10,600

EBITDA

63M

566M

Recomendações

By TipRanks

Recomendações

Comprar

Previsão para 12 meses

+19.04% upside

Dividendos

By Dow Jones

Rendimento de Dividendos

Médio do Setor

0.83%

2.26%

Próximos Ganhos

22 de abr. de 2026

Próxima data de dividendos

19 de mar. de 2026

Próxima data de ex-dividendo

7 de mai. de 2026

Estatísticas de Mercado

By TradingEconomics

Capitalização de Mercado

3B

40B

Abertura anterior

257.74

Fecho anterior

258.44

Sentimento de Notícias

By Acuity

11%

89%

12 / 351 Ranking em Healthcare

ResMed Inc Gráfico

O desempenho passado não é um indicador confiável de resultados futuros.

Notícias Relacionadas

17 de fev. de 2026, 23:44 UTC

Ações em Alta

Stocks to Watch: La-Z-Boy, Palo Alto Networks, Caesars

17 de fev. de 2026, 23:20 UTC

Ganhos

Palo Alto Networks Lifts FY26 Revenue Outlook as 2Q Profit Jumps -- Update

17 de fev. de 2026, 22:57 UTC

Ganhos

Santos Fiscal Year Net Profit Falls 33%, Nears Start of Alaska Project

17 de fev. de 2026, 21:59 UTC

Ganhos

Palo Alto Networks Lifts FY26 Revenue Outlook as 2Q Profit Jumps

17 de fev. de 2026, 23:54 UTC

Conversa de Mercado

Nikkei May Rise as Fears About AI Disruption Ease -- Market Talk

17 de fev. de 2026, 23:54 UTC

Conversa de Mercado

Global Equities Roundup: Market Talk

17 de fev. de 2026, 23:54 UTC

Conversa de Mercado

Global Forex and Fixed Income Roundup: Market Talk

17 de fev. de 2026, 23:45 UTC

Conversa de Mercado

Suncorp's Outperformance of IAG Could Be Hard to Sustain -- Market Talk

17 de fev. de 2026, 23:19 UTC

Ganhos

Palo Alto's Guidance Overshadows Strong Earnings. Its Stock Is Down. -- Barrons.com

17 de fev. de 2026, 23:15 UTC

Ganhos

Palo Alto's Guidance Overshadows Strong Earnings. Its Stock Is Down. -- Barrons.com

17 de fev. de 2026, 22:58 UTC

Conversa de Mercado
Aquisições, Fusões, Aquisições de Empresas

Netflix Would Operate Warner's Studios, HBO Largely the Same -- Market Talk

17 de fev. de 2026, 22:58 UTC

Aquisições, Fusões, Aquisições de Empresas

BlueScope Steel: Board Committed to Optimizing Value For Shareholders

17 de fev. de 2026, 22:57 UTC

Aquisições, Fusões, Aquisições de Empresas

BlueScope Steel to Consider Revised SGH, Steel Dynamics Takeover Bid

17 de fev. de 2026, 22:50 UTC

Aquisições, Fusões, Aquisições de Empresas

Agnico-Eagle Mines Acquired 662,780 Common Shrs of Maple Gold Mines at C$2.45 Per Common Shr >AEM.T

17 de fev. de 2026, 22:44 UTC

Ganhos

Palo Alto Reports Strong Earnings. Its Stock Is Down. -- Barrons.com

17 de fev. de 2026, 22:42 UTC

Ganhos

Santos FY Net Profit Falls 33%, Nears Start of Alaska Project

17 de fev. de 2026, 22:36 UTC

Conversa de Mercado
Aquisições, Fusões, Aquisições de Empresas

Netflix Sarandos: Paramount Causing Confusion Around Warner Deal -- Market Talk

17 de fev. de 2026, 22:36 UTC

Ganhos

Santos Final Dividend 10.3 U.S. Cents/Security

17 de fev. de 2026, 22:36 UTC

Ganhos

Santos FY Underlying Profit US$898 Million, Down 25%

17 de fev. de 2026, 22:35 UTC

Ganhos

Santos FY Revenue US$4.94 Billion, Down 8%

17 de fev. de 2026, 22:35 UTC

Ganhos

Correct: Santos FY Net Profit US$818 Million, Down 33%

17 de fev. de 2026, 22:35 UTC

Aquisições, Fusões, Aquisições de Empresas

Berkshire Buys New York Times Stock; Sells Apple, Bank of America, Amazon In 4Q -- Barrons.com

17 de fev. de 2026, 22:34 UTC

Ganhos

Santos FY Net Profit US$818 Billion, Down 33%

17 de fev. de 2026, 22:02 UTC

Aquisições, Fusões, Aquisições de Empresas

Berkshire Pares Stakes in Apple and BofA, Adds New York Times Position -- Update

17 de fev. de 2026, 21:50 UTC

Aquisições, Fusões, Aquisições de Empresas

Steel Dynamics: SGH Would Buy BlueScope, On-sell North American Operations to SDI, As Earlier Proposed

17 de fev. de 2026, 21:50 UTC

Conversa de Mercado
Aquisições, Fusões, Aquisições de Empresas

Tech, Media & Telecom Roundup: Market Talk

17 de fev. de 2026, 21:50 UTC

Conversa de Mercado

Basic Materials Roundup: Market Talk

17 de fev. de 2026, 21:49 UTC

Aquisições, Fusões, Aquisições de Empresas

Steel Dynamics Says Revised Proposal Continues to Present Highly Strategic Opportunity For SDI Shareholders

17 de fev. de 2026, 21:48 UTC

Aquisições, Fusões, Aquisições de Empresas

Steel Dynamics: BlueScope Offer a 56% Premium to 52-Week Volume Weighted Average Price

17 de fev. de 2026, 21:48 UTC

Aquisições, Fusões, Aquisições de Empresas

Steel Dynamics: Consideration To Be Comprised Entirely of Cash

Comparação entre Pares

Variação de preço

ResMed Inc Previsão

Preço-alvo

By TipRanks

19.04% parte superior

Previsão para 12 meses

Média 300.64 USD  19.04%

Máximo 345 USD

Mínimo 265 USD

Com base em 13 analistas de Wall Street que oferecem metas de preço de 12 meses para ResMed Inc - Dist nos últimos 3 meses.

Consenso de Avaliação

By TipRanks

Comprar

13 ratings

8

Comprar

5

Manter

0

Vender

Sentimento

By Acuity

12 / 351 Ranking em Saúde

Sentimento de Notícias

Evidência Muito Forte de Tendência de Alta

Volatilidade

Abaixo da média

Volume de Notícias (RCV)

Acima da média

Informação Financeira

Custos administrativos e de venda

Custos Operacionais

Lucro antes de imposto

Vendas

Custo das vendas

Lucro bruto sobre vendas

Despesa com juros da dívida

EBITDA

Resultado Operacional

$

Sobre ResMed Inc

ResMed Inc. develops, manufactures, distributes, and markets medical devices and cloud-based software applications for the healthcare markets. The company operates in two segments, Sleep and Respiratory Care, and Software as a Service. It offers various products and solutions for a range of respiratory disorders, including ApneaLink Air, a portable diagnostic device that measures oximetry, respiratory effort, pulse, nasal flow, and snoring; and NightOwl, a portable, cloud-connected, and disposable diagnostic device that measures AHI based on derived peripheral arterial tone, actigraphy, and oximetry over several nights. The company also provides AirView, a cloud-based system that enables remote monitoring and changing of patients' device settings; myAir, a personalized therapy management application for patients with sleep apnea that provides support, education, and troubleshooting tools for increased patient engagement and improved compliance; U-Sleep, a compliance monitoring solution that enables home medical equipment (HME) to streamline their sleep programs; connectivity module and propeller solutions; and Propeller portal. It offers out-of-hospital software solution, such as Brightree business management software and service solutions to providers of HME, pharmacy, home infusion, orthotics, and prosthetics services; MatrixCare care management and related ancillary solutions to senior living, skilled nursing, life plan communities, home health, home care, and hospice organizations, as well as related accountable care organizations; HEALTHCAREfirst that offers electronic health record, software, billing and coding services, and analytics for home health and hospice agencies; and MEDIFOX DAN's software solutions. The company markets its products to sleep clinics, home healthcare dealers, and hospitals through a network of distributors and direct sales force. ResMed Inc. was founded in 1989 and is headquartered in San Diego, California.
help-icon Live chat